From Tier Table Database
CDC Office of Public Health Genomics (OPHG) conducts horizon scanning (a systematic research method to find and follow novel technologies appearing in the literature) to identify and track the progress of genomic tests as they move from research into clinical and public health practice. As an aid in organizing horizon scanning results, OPHG ranks genomic tests, and family health history applications, by levels of evidence. See detail.
| Disease/Disorder | Test to be Assessed | Intended Use | Tier Classified | Detail |
|---|---|---|---|---|
| Schizophrenia, bipolar I disorder, autistic disorder | CYP2D6 | Pharmacogenoic for risperidone, dose | Tier 2  | |
| Schizophrenia, bipolar I disorder, major depressive disorder, autistic disorder | CYP2D6 | Pharmacogenomic for aripiprazole, dose | Tier 2 |
No hay comentarios:
Publicar un comentario